Fuad Elkhoury
YOU?
Author Swipe
View article: Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study
Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study Open
View article: Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation
Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation Open
OBJECTIVE. The purpose of this study was to compare in a multireader manner the diagnostic accuracies of 3-T multiparametric MRI interpretation and serial prostate-specific antigen (PSA) measurement in predicting the presence of res…
View article: Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive
Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive Open
An MRI-visible lesion in men undergoing first-time prostate biopsy identifies those with a heightened risk of clinically significant prostate cancer. Combining targeted and systematic biopsy offers the best chances of detecting the cancer.
View article: Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate Cancer
Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate Cancer Open
OBJECTIVE. The purpose of this article is to evaluate restriction spectrum imaging (RSI) in men undergoing MRI-ultrasound fusion biopsy for suspected prostate cancer (PCa) and to compare the performance of RSI with that of conventio…
View article: LBA-11 PAIREDCAP TRIAL: PROSPECTIVE ASSESSMENT OF IMAGE REGISTRATION IN DIAGNOSIS OF PROSTATE CANCER
LBA-11 PAIREDCAP TRIAL: PROSPECTIVE ASSESSMENT OF IMAGE REGISTRATION IN DIAGNOSIS OF PROSTATE CANCER Open
You have accessJournal of UrologySunday Next Frontier (LBA)1 Apr 2019LBA-11 PAIREDCAP TRIAL: PROSPECTIVE ASSESSMENT OF IMAGE REGISTRATION IN DIAGNOSIS OF PROSTATE CANCER Rajiv Jayadevan*, Fuad Elkhoury, Ely Felker, Lorna Kwan, Anthony Sisk…
View article: MP14-15 RESTRICTION SPECTRUM IMAGING IN PROSTATE CANCER DIAGNOSIS
MP14-15 RESTRICTION SPECTRUM IMAGING IN PROSTATE CANCER DIAGNOSIS Open
You have accessJournal of UrologyImaging/Radiology: Uroradiology I1 Apr 2018MP14-15 RESTRICTION SPECTRUM IMAGING IN PROSTATE CANCER DIAGNOSIS Fuad Elkhoury, Ely Felker, Lorna Kwan, Steven Raman, David Lu, Sepideh Shakeri, Pooria Khoshnoodi…
View article: PD23-01 TARGETED VS STANDARD PROSTATE BIOPSY: A PROSPECTIVE TRIAL IN BIOPSY-NAIVE MEN
PD23-01 TARGETED VS STANDARD PROSTATE BIOPSY: A PROSPECTIVE TRIAL IN BIOPSY-NAIVE MEN Open
You have accessJournal of UrologyProstate Cancer: Detection & Screening II1 Apr 2018PD23-01 TARGETED VS STANDARD PROSTATE BIOPSY: A PROSPECTIVE TRIAL IN BIOPSY-NAIVE MEN Fuad Elkhoury, Shyam Natarajan, Lorna Kwan, Ely Felker, Merdie Delfin…
View article: MP40-02 TARGETED PROSTATE BIOPSY: CANCER EXTENDS BEYOND THE ROI!
MP40-02 TARGETED PROSTATE BIOPSY: CANCER EXTENDS BEYOND THE ROI! Open
You have accessJournal of UrologyProstate Cancer: Detection & Screening III1 Apr 2018MP40-02 TARGETED PROSTATE BIOPSY: CANCER EXTENDS BEYOND THE ROI! Alan Priester, Fuad Elkhoury, Jacob Vandel, Merdie Delfin, Ely Felker, Shyam Natarajan, a…
View article: MP30-04 MRI-GUIDED BIOPSY FOLLOWING FOCAL LASER ABLATION OF PROSTATE CANCER: SUBSEQUENT OUTCOMES OF 2 CLINICAL TRIALS
MP30-04 MRI-GUIDED BIOPSY FOLLOWING FOCAL LASER ABLATION OF PROSTATE CANCER: SUBSEQUENT OUTCOMES OF 2 CLINICAL TRIALS Open
23% of biopsies performed of the treatment site at 6 mos.post therapy.We observed a 45% decrease in mean PSA at 12 months post therapy and no statistically significant change in IPSS and SHIM scores.CONCLUSIONS: Our data indicate that outp…
View article: MP20-16 <sup>68</sup> GA-PSMA-11 PET/CT VS <sup>18</sup> F-FLUCICLOVINE PET/CT: A CASE SERIES IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL RECURRENCE
MP20-16 <sup>68</sup> GA-PSMA-11 PET/CT VS <sup>18</sup> F-FLUCICLOVINE PET/CT: A CASE SERIES IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL RECURRENCE Open
You have accessJournal of UrologyImaging/Radiology: Uroradiology II1 Apr 2018MP20-16 68GA-PSMA-11 PET/CT VS 18F-FLUCICLOVINE PET/CT: A CASE SERIES IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL RECURRENCE Fuad Elkhoury, Jeremie Calais, Johan…
View article: MR-guided biopsy and focal therapy
MR-guided biopsy and focal therapy Open
MRI-guided biopsy is optimizing prostate cancer diagnosis. Focal therapy, an outgrowth of guided biopsy, promises to become a well tolerated and effective approach to treating many men with prostate cancer while minimizing the risks of inc…
View article: Targeted Prostate Biopsy in the Era of Active Surveillance
Targeted Prostate Biopsy in the Era of Active Surveillance Open
View article: Optimization of urinary dipstick pH: Are multiple dipstick pH readings reliably comparable to commercial 24-hour urinary pH?
Optimization of urinary dipstick pH: Are multiple dipstick pH readings reliably comparable to commercial 24-hour urinary pH? Open
We concluded that urinary dipstick based pH measurement lacks the precision required to guide medical management of nephrolithiasis and physicians should use 24-hour urine analysis to base their metabolic therapy.